Treatment of pemphigus: The need for more evidence

Archives of Dermatology

Volumn 144, Issue 1, 2008, Pages 100-101

  Martin, Linda K ^b   Murrell, Dedee F ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID; PLACEBO; PREDNISONE;

CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE CONTROL; DRUG EFFICACY; EDITORIAL; HUMAN; MORBIDITY; MORTALITY; PEMPHIGUS; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

DAPSONE; DRUG THERAPY, COMBINATION; HUMANS; NEEDS ASSESSMENT; PEMPHIGUS; PREDNISONE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 38549128857     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archdermatol.2007.14     Document Type: Editorial

References (18)

1. Martin LK, Werth VP, Agero AL, Villaneuva EV, Segall JD, Murrell DF. Interventions for pemphigus vulgaris and pemphigus foliaceus. (protocol). Cochrane Database Syst Rev. 2006;(4):CD006263.
2. Kaufman DB, Shapiro R, Lucey MR, Cherikh WS, Bustami R, Dyke DB. Immunosuppression: practice and trends. Am J Transplant. 2004;4(suppl 9):38-53.
3. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum. 1996;39(5):713-722.
4. Werth VP, Fivenson D, Pandya AG, et al. Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. Arch Dermatol. 2008;144(1):25-32.
5. Auad A, Auad T, Auad A, Auad P. Terpêutica coadjuvante no tratamento do penfigo foliaceo sul-americano com auranofina: estudo duplo-cego. An bras Dermatol. 1986;61(3):131-134.
6. Tabrizi MN, Chams-Davatchi C, Esmaeeli N, et al. Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial. J Eur Acad Dermatol Venereol. 2007;21(1):79-84.
7. Mentink LF, Mackenzie MW, Toth GG, et al. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial [published correction for error in dosage appears in Arch Dermatol. 2006;142(8):1014]. Arch Dermatol. 2006;142(5):570-576.
8. Ioannides D, Chrysomallis F, Bystryn JC. Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol. 2000;136(7):868-872.
9. Chrysomallis F, Ioannides D, Teknetzis A, Panagiotidou D, Minas A. Treatment of oral pemphigus vulgaris. Int J Dermatol. 1994;33(11):803-807.
10. Rose E, Wever S, Zillikens D, Linse R, Haustein UF, Brocker EB. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. J Dtsch Dermatol Gesell. 2005;3(3):200-206.
11. Chams-Davatchi C, Esmali N, Daneshpazhooh M, et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol. 2007;57(4):622-628.
12. Guillaume JC, Roujeau JC, Morel P, et al. Controlled study of plasma exchange in pemphigus. Arch Dermatol. 1988;124(11):1659-1663.
13. Ratnam KV, Phay KL, Tan CK. Pemphigus therapy with oral prednisolone regimens: a 5-year study. Int J Dermatol. 1990;29(5):363-367.
14. Beissert S, Werfel T, Frieling U, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol. 2006;142(11):1447-1454.
15. Luo X, Zhu L, Tao L, et al. The clinical and laboratory research for Chinese traditional medicine in the treatment of pemphigus [in Chinese]. J Clin Dermatol. 2003;32(1):38-41.
16. Martin L, Murrell DF. Measuring the immeasurable: a systematic review of outcomes measures in pemphigus. Australas J Dermatol. 2006;47(suppl 1):A32-A33.
17. Joly P, Roujeau JC, Benichou J, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346(5):321-327.
18. Joly P, Mouquet H, Roujeau JC, et al. A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med. 2007;357(6):545-552.